Dipna Pharmachem (BOM:543594) Change In Receivables : ₹-92 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Change In Receivables?

Dipna Pharmachem's change in receivables for the quarter that ended in Sep. 2024 was ₹-159 Mil. It means Dipna Pharmachem's Accounts Receivable increased by ₹159 Mil from Mar. 2024 to Sep. 2024 .

Dipna Pharmachem's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-24 Mil. It means Dipna Pharmachem's Accounts Receivable increased by ₹24 Mil from Mar. 2023 to Mar. 2024 .

Dipna Pharmachem's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹469 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dipna Pharmachem's Days Sales Outstanding for the six months ended in Sep. 2024 was 94.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dipna Pharmachem's liquidation value for the six months ended in Sep. 2024 was ₹-471 Mil.

Dipna Pharmachem Change In Receivables Historical Data

The historical data trend for Dipna Pharmachem's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Change In Receivables Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

-21.12

-46.36

-120.27

-15.57

-24.05

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial				-23.38	7.81	-91.51	67.46	-159.31

Dipna Pharmachem Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-92 Mil.

Dipna Pharmachem (BOM:543594) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dipna Pharmachem's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	468.675	/	906.238	*	91
=	94.38

2. In Ben Graham's calculation of liquidation value, Dipna Pharmachem's accounts receivable are only considered to be worth 75% of book value:

Dipna Pharmachem's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.201	-	952.613	+	0.75 * 468.675	+	0.5 * 259.834
=	-471

Dipna Pharmachem Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dipna Pharmachem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.

Dipna Pharmachem Headlines

No Headlines